ANN ARBOR, MI, UNITED STATES, April 3, 2025 – GreenMark Biomedical Inc., a pioneer in leveraging biomimetic technology for dental health innovations, announces that it has received a Phase I Small Business Innovation Research (SBIR) grant in the amount of US $ 294,632 from the National Institutes of Health (NIH).
Read More ANN ARBOR, MI, UNITED STATES, January 22, 2025 – Great Oral Health adopts CrystLCare™ Biorestorative, Fluoride-Free dental strips into its product line to help combat dental sensitivity and strengthen enamel.
Read More ANN ARBOR, MI, UNITED STATES, January 7, 2025 – GreenMark Biomedical Inc., a pioneer in leveraging biomimetic technology for dental health innovations, today announced that the company has secured regulatory clearance from the U.S. Food and Drug Administration (FDA) to market its CrystLCare™ PRO Biorestorative, Fluoride-Plus product as a 510(k) Class II Medical Device.
Read More “The study reveals compelling in vitro data supporting GreenMark’s CrystLCare™ Biorestorative technology, which offers a non-invasive solution for addressing early-stage dental caries. This breakthrough research resulted from an NIH-funded collaboration of investigators at top dental schools together with the GreenMark team.”
Read More ANN ARBOR, MI, UNITED STATES, May 22, 2024 – GreenMark Biomedical Inc., a pioneer in leveraging biomimetic nanotechnology for dental health innovations, proudly announces a strategic partnership with Dentulu, Inc., the leader in online preventative dental solutions. This partnership heralds the introduction of a first product, CrystLCare™ Biorestorative, Fluoride-Free, in a GreenMark-Dentulu co-branded product line, providing groundbreaking solutions designed to […]
Read More Ann Arbor, MI, May 16, 2024 – GreenMark Biomedical Inc. announces it will receive up to $200,000 in additional funding to advance its innovative regenerative technology toward products for dental sensitivity treatment and noninvasive mineralization of early-stage dental decay. To date GreenMark raised $8.6 million in equity investment and non-dilutive funding. In the final year […]
Read MoreAugust 24, 2020 – GreenMark Biomedical Inc. announced that the company raised $1.74M in equity financing in the form of convertible notes in anticipation of a Series A financing in 2021
Read More